Literature DB >> 15276925

Drugs and driving.

J Michael Walsh1, Johan J de Gier, Asbjørg S Christopherson, Alain G Verstraete.   

Abstract

The authors present a global overview on the issue of drugs and driving covering four major areas: (1) Epidemiology and Prevalence--which reviews epidemiological research, summarizes available information, discusses the methodological shortcomings of extant studies, and makes recommendations for future research to better define prevalence and epidemiology; (2) Effects of Medicinal and Illegal Drugs on Driving Performance--focuses on the six classes of drugs most often found in impaired and injured drivers, draws conclusions regarding the risk of these drugs to traffic safety and discusses the need for additional research; (3) Toxicological Issues--discusses ways to identify drug users via behavioral testing and analytical techniques, reviews the approaches used by different countries, screening and confirmation techniques, alternative specimens (e.g., urine, oral fluid, sweat), and how rapid roadside testing could be coupled with behavioral and laboratory testing in an effective approach to identifying and prosecuting drugged drivers; (4) Driving Under the Influence of Drugs [DUID] Laws--provides an overview of DUID laws in the United States and Europe, discusses the basic tenets of these laws, the various types of DUID statutes, the reasons why many existing laws hinder the prosecution of drugged drivers and the rationale for developing per se legislation as a strategy to more effectively manage the drugged driver problem.

Mesh:

Year:  2004        PMID: 15276925     DOI: 10.1080/15389580490465292

Source DB:  PubMed          Journal:  Traffic Inj Prev        ISSN: 1538-9588            Impact factor:   1.491


  33 in total

1.  Prevalence of alcohol and other drugs in fatally injured drivers.

Authors:  Joanne E Brady; Guohua Li
Journal:  Addiction       Date:  2012-08-20       Impact factor: 6.526

2.  Cannabinoid disposition in oral fluid after controlled smoked cannabis.

Authors:  Dayong Lee; David M Schwope; Garry Milman; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-01-24       Impact factor: 8.327

3.  The impact of cannabis on driving.

Authors:  Michel Bédard; Sacha Dubois; Bruce Weaver
Journal:  Can J Public Health       Date:  2007 Jan-Feb

Review 4.  The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies.

Authors:  Ludivine Orriols; Louis-Rachid Salmi; Pierre Philip; Nicholas Moore; Bernard Delorme; Anne Castot; Emmanuel Lagarde
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-08       Impact factor: 2.890

5.  Road traffic accidents and psychotropic medication use in The Netherlands: a case-control study.

Authors:  Silvia Ravera; Nienke van Rein; Johan J de Gier; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

6.  Guidelines for research on drugged driving.

Authors:  J Michael Walsh; Alain G Verstraete; Marilyn A Huestis; Jørg Mørland
Journal:  Addiction       Date:  2008-08       Impact factor: 6.526

Review 7.  Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review.

Authors:  Toni M Rudisill; Motao Zhu; George A Kelley; Courtney Pilkerton; Brandon R Rudisill
Journal:  Accid Anal Prev       Date:  2016-08-29

8.  Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.

Authors:  Eugene W Schwilke; David M Schwope; Erin L Karschner; Ross H Lowe; William D Darwin; Deanna L Kelly; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

9.  Effects of alcohol on automated and controlled driving performances.

Authors:  Catherine Berthelon; Guy Gineyt
Journal:  Psychopharmacology (Berl)       Date:  2013-11-30       Impact factor: 4.530

10.  The use of driving impairing medicines: a European survey.

Authors:  Silvia Ravera; Sylvia A Hummel; Pieter Stolk; Rob E Heerdink; Lolkje T W de Jong-van den Berg; Johan J de Gier
Journal:  Eur J Clin Pharmacol       Date:  2009-07-21       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.